Evidence map›Paper›PMID 30982170›Full record

SynthesisObesity surgery2019

Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal.

Zubair Khan, Muhammad Ali Khan, Kaveh Hajifathalian, Shawn Shah, Mohamed Abdul, Monica Saumoy, Louis Aronne, Wade Lee, Reem Z Sharaiha

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Obesity surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2020
    Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Endoscopic bariatrics: Current status and emerging technologies.World journal of gastrointestinal endoscopy · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Bariatric and Metabolic Endoscopy: A New Paradigm.Clinical and translational gastroenterology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zubair KhanDivision of Gastroenterology, University of Toledo, Toledo, OH, USA.
Muhammad Ali KhanDivision of Gastroenterology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-8235-1733
Kaveh HajifathalianDivision of Gastroenterology, Weill Cornell College of Medicine, New York, NY, USA.
Shawn ShahDivision of Gastroenterology, Weill Cornell College of Medicine, New York, NY, USA.
Mohamed AbdulDivision of Gastroenterology, University of Alabama at Birmingham, Birmingham, AL, USA.
Monica SaumoyDivision of Gastroenterology, Weill Cornell College of Medicine, New York, NY, USA.
Louis AronneDivision of Gastroenterology, Weill Cornell College of Medicine, New York, NY, USA.
Wade LeeDivision of Gastroenterology, University of Toledo, Toledo, OH, USA.
Reem Z SharaihaDivision of Gastroenterology, Weill Cornell College of Medicine, New York, NY, USA. rsharaiha@gmail.com.
Cornell University · USUniversity of Alabama at Birmingham · USUniversity of Toledo · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsNovel endoscopic procedures (endoscopic sleeve gastroplasty (ESG), AspireAssist (AA), and primary obesity surgery endolumenal (POSE)) have been developed for treatment of obesity. We aimed to conduct a systematic review and meta-analysis to evaluate and compare the efficacy of these three endoscopic procedures.

methodsMain outcomes of interest were percent excess weight loss (%EWL) and percent total body weight loss (%TBWL). Weighted pooled means (WPMs) were calculated and analyzed using random effects model. Mean differences (MDs) were calculated to compare these procedures.

resultsTwelve studies with 1149 patients were included. WPMs for %EWL at 6 and 12 months with ESG were 49.67 (45.67, 53.66) and 52.75 (43.52, 61.98), respectively, while %TBWLs at 6 and 12 months with ESG were 16.01 (15.10, 16.92) and 17.41 (17.08, 17.74), respectively. WPMs for %EWL at 6 and 12 months with POSE were 43.79 (40.17, 47.42) and 44.91 (40.90, 48.92), respectively. WPM for %EWL at 12 months with AA was 50.85 (46.03, 55.68). While comparing ESG and POSE, at 6 months and 12 months, MD for %EWL was 6.17 (1.07, 11.26; P = 0.01) and 7.84 (- 2.05, 17.71; P = 0.06) in favor of ESG. No difference in %EWL was observed while comparing ESG with AA (P = 0.29). Likewise, MD for %EWL to compare AA and POSE was not significant (P = 0.68).

conclusionsDuring a follow-up of 6-12 months, both AA and ESG had excellent efficacy in achieving significant and sustained weight loss; however, ESG was found to be superior in terms of weight loss when compared with POSE.

Indexed as

Bariatric SurgeryEndoscopyGastroplastyHumansObesityTreatment OutcomeWeight LossAspireAssistBariatric endoscopyObesityPOSESleeve gastroplasty

Identifiers

PMID30982170
OpenAlexW2938494388

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.